Basics Anika Therapeutics Inc. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. IPO Date: January 3, 1994 Sector: Healthcare Industry: Biotech Market Cap: $169.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 1.98% Avg Daily Range (30 D): $0.34 | 2.57% Avg Daily Range (90 D): $0.28 | 1.89% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .05M Trade Size Avg Trade Size (Sh.): 102 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 44 Institutional Trades Total Inst.Trades: 1,255 Avg Inst. Trade: $1.25M Avg Inst. Trade (30 D): $.88M Avg Inst. Trade (90 D): $.7M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $.88M Avg Closing Volume: 33.15K         News May 12, 2025 @ 9:00 PM Anika Reports Inducement Grants Under Nasdaq Listi... Source: N/A Mar 7, 2025 @ 11:00 AM Anika Completes Divestiture of Parcus Medical Source: Anika Therapeutics, Inc. Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research Oct 17, 2024 @ 8:01 PM Anika Announces Third Quarter 2024 Results Confere... Source: N/A Aug 15, 2024 @ 8:01 PM Anika Reports Inducement Grants Under Nasdaq Listi... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.87 $-.34 $-1.49 Diluted EPS $-3.87 $-.34 $-1.49 Revenue $ 105.55M $ 26.17M $ -1.29M Gross Profit $ 66.05M $ 14.68M $ 22.57M Net Income / Loss $ -56.74M $ -4.87M $ -21.87M Operating Income / Loss $ -4.32M $ -4.28M $ 27.82M Cost of Revenue $ 39.5M $ 11.49M $ -23.86M Net Cash Flow $ -15.35M $ -3.9M $ -5.08M PE Ratio